Quest for the right Drug
פרובין FERROVIN (IRON SUCROSE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי : I.V
צורת מינון:
תמיסה להזרקה : SOLUTION FOR INJECTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Posology : מינונים
4.2 Posology and method of administration Monitor carefully patients for signs and symptoms of hypersensitivity reactions during and following each administration of FERROVIN. FERROVIN should only be administered when staff trained to evaluate and manage anaphylactic reactions is immediately available, in an environment where full resuscitation facilities can be assured. The patient should be observed for adverse effects for at least 30 minutes following each FERROVIN administration (see section 4.4). Posology The cumulative dose of FERROVIN must be calculated for each patient individually and must not be exceeded. Calculation of Dosage: The total cumulative dose of FERROVIN, equivalent to the total iron deficit (mg), is determined by the haemoglobin level (Hb) and body weight (BW). The dose of FERROVIN must be individually calculated for each patient according to the total iron deficit calculated with the following Ganzoni formula, for example: Total iron deficit [mg] = BW [kg] X (target Hb- actual Hb) [g/dl] X 2.4* + storage iron [mg] • Below 35 kg BW: Target Hb= 13g/dl and storage iron= 15mg/kg BW • 35 kg BW and above: Target Hb= 15g/dl and storage iron= 500 mg *Factor 2.4 = 0.0034 (iron content of Hb=0.34%) x 0.07 (blood volume=7% of BW) x 1000 (conversion of [g] to [mg]) x 10 Total FERROVIN to be administered (in ml)= Total iron deficit [mg] 20 mg iron/ml Total amount of FERROVIN (ml) to be administered according to body weight, actual Hb level and target Hb level*: Body weight Total amount of FERROVIN (20mg iron per ml) to be administered: [kg] Hb 6.0 g/dl Hb 7.5 g/dl Hb 9.0 g/dl Hb 10.5 g/dl 30 47.5ml 42.5ml 37.5ml 32.5ml 35 62.5ml 57.5ml 50ml 45ml 40 67.5ml 60ml 55ml 47.5ml 45 75ml 65ml 57.5ml 50ml 50 80ml 70ml 60ml 52.5ml 55 85ml 75ml 65ml 55ml 60 90ml 80ml 67.5ml 57.5ml 65 95ml 82.5ml 72.5ml 60ml 70 100ml 87.5ml 75ml 62.5ml 75 105ml 92.5ml 80ml 65ml 80 112.5ml 97.5ml 82.5ml 67.5ml 85 117.5ml 102.5ml 85ml 70ml 90 122.5ml 107.5ml 90ml 72.5ml Below 35 kg BW: Target HB=13 g/dl 35 kg BW and above: Target Hb=15 g/dl To convert Hb (mM) to Hb (g/dl), multiply the former by 1.6. If the total necessary dose exceeds the maximum allowed single dose, then the administration must be divided. Posology: Adults: 5-10ml of FERROVIN (100-200 mg iron) one to three times a week. For administration time and dilution ration see "Method of administration". Paediatric population: The use of iron sucrose has not been adequately studied in children and, therefore, FERROVIN is not recommended for use in children. Method of Administration: FERROVIN must only be administered by the intravenous route. This may be by a slow intravenous injection, by an intravenous drip infusion or directly into the venous line of the dialysis machine. Intravenous drip infusion: FERROVIN must only be diluted in sterile 0.9% m/V sodium chloride (NaCl) solution. Dilution must take place immediately prior to infusion and the solution should be administered as follows: FERROVIN dose FERROVIN dose Maximum dilution Minimum Infusion (mg of iron) (ml of FERROVIN) volume of sterile Time 0.9% m/V NaCl solution 50 mg 2.5 ml 50 ml 8 minutes 100 mg 5 ml 100 ml 15 minutes 200 mg 10 ml 200 ml 30 minutes For stability reasons, dilutions to lower FERROVIN concentrations are not permissible. Intravenous injection: FERROVIN may be administered by slow intravenous injection at a rate of 1 ml undiluted solution per minute and not exceeding 10 ml FERROVIN (200 mg iron) per injection. Injection into venous line of dialysis machine: FERROVIN may be administered during a haemodialysis session directly into the venous line of the dialysis machine under the same conditions as for intravenous injection.
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
יצרן
RAFARM S.A., GREECEבעל רישום
LAPIDOT MEDICAL IMPORT AND MARKETING LTDרישום
141 09 31806 00
מחיר
0 ₪
מידע נוסף